CDSCO

Biplab Lenin, Partner; and Anam Chowdhary, Associate, Cyril Amarchand Mangaldas, stress that regulatory vigilance on the…

Durvalumab in combination with carboplatin and paclitaxel is now also indicated for first-line treatment of adults with primary…

The approval follows evidence from the Phase III LAURA trial, which demonstrated significant clinical benefits in delaying disease…

Dr Saurabh Arora, Managing Director, Auriga Research, explains how prioritising integrity, infrastructure, digital systems, and…

The medicine is now indicated as a monotherapy for the treatment of adult patients with unresectable or metastatic breast cancer

At the Ahmedabad Pharma Summit 2025, Ganesh Boddu, GMRegulatory Affairs & Clinical Research, Eris Life Sciences delivered a…

If the QR code system is not all that it was promised to be, what are the next steps to safeguard our medicines?

Phase 3 SURPASS programme demonstrated that Mounjaro, whether used alone or with other diabetes medications, reduced A1C by up to…

A structured and well-documented Gap Analysis is essential for identifying deficiencies, strengthening compliance, and ensuring…

This treatment can enhance hyperkalaemia management in adults, a condition characterised by elevated potassium levels that often…